[XENE] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
06-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 11.76%
YoY- -28.28%
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 7,078 3,329 3,500 0 0 6,000 0 -
PBT -7,485 -11,412 -8,866 -10,036 -11,304 -8,558 -14,383 -35.27%
Tax -1 -36 5 -29 37 357 678 -
NP -7,484 -11,376 -8,871 -10,007 -11,341 -8,558 -14,383 -35.28%
Tax Rate - - - - - - - -
Total Cost 14,562 14,705 12,371 10,007 11,341 14,558 14,383 0.82%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -105.74 -341.72 -253.46 0.00 0.00 -142.63 0.00 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -0.23 -0.34 -0.34 -0.39 -0.44 -0.34 -0.71 -52.79%
EPS Diluted -0.23 -0.34 -0.34 -0.39 -0.44 -0.33 -0.71 -52.79%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.